Amorphous cefuroxime axetil and preparation process therefore

    公开(公告)号:US20060020130A1

    公开(公告)日:2006-01-26

    申请号:US11187555

    申请日:2005-07-22

    IPC分类号: C07D501/00 A61K9/14

    CPC分类号: C07D501/00

    摘要: A novel process for the preparation of amorphous cefuroxime axetil particles and the amorphous cefuroxime axetil particles therefrom are disclosed in the invention. Specifically, the invention is implemented by means of antisolvent recrystallization to prepare the cefuroxime axetil in an amorphous form; particularly, the amorphous ultrafine or even nanosized cefuroxime axetil with a controllable particle size and a narrow particle size distribution. The cefuroxime axetil according to the invention can used to enhance bioavailability, since it is in an amorphous form and has a controllable particle size and a narrow particle size distribution.

    Amorphous cefuroxime axetil and preparation process therefore
    6.
    发明授权
    Amorphous cefuroxime axetil and preparation process therefore 有权
    无定形头孢呋辛酯及其制备方法

    公开(公告)号:US07507813B2

    公开(公告)日:2009-03-24

    申请号:US11187555

    申请日:2005-07-22

    IPC分类号: C07D501/34

    CPC分类号: C07D501/00

    摘要: A novel process for the preparation of amorphous cefuroxime axetil particles and the amorphous cefuroxime axetil particles therefrom are disclosed in the invention. Specifically, the invention is implemented by means of antisolvent recrystallization to prepare the cefuroxime axetil in an amorphous form; particularly, the amorphous ultrafine or even nanosized cefuroxime axetil with a controllable particle size and a narrow particle size distribution. The cefuroxime axetil according to the invention can used to enhance bioavailability, since it is in an amorphous form and has a controllable particle size and a narrow particle size distribution.

    摘要翻译: 在本发明中公开了一种用于制备无定形头孢呋辛酯颗粒和无定形头孢呋辛酯颗粒的新方法。 具体地说,本发明是通过抗溶剂重结晶实现的,以制备无定形形式的头孢呋辛酯; 特别是具有可控粒度和窄粒度分布的无定形超细或甚至纳米尺寸的头孢呋辛酯。 根据本发明的头孢呋辛酯可用于提高生物利用度,因为其为无定形形式并且具有可控的粒度和窄的粒度分布。